The World Health Organization issues Rapid Communication on key updates to the treatment of drug-resistant TB.

WHO releases updated Target Product Profiles for TB diagnosis and detection of drug resistance.

In a concerted effort to advance work towards achieving the long-term goal of eliminating TB, the World Health Organization (WHO) has initiated efforts to support countries during the validation of TB elimination, alongside establishing necessary governance structures to monitor progress.

The World Health Organization (WHO) provided updates on several important events hosted by the organization and its partners in June 2024 in Dhaka, Bangladesh: first Global Forum on Advancing Multisectoral and Multistakeholder Engagement and Accountability to End TB (23-24 June); #Youth2EndTB Townhall (23 June); annual meeting of the Stop TB Working Group on Public-Private Mix (PPM) for TB prevention and care (25-26 June); consultation on enhanced TB-PPM data dashboards with seven PPM priority countries (27 June). The WHO policy brief: "Public-Private Mix Data Dashboards for Enhanced Action and Accountability to End TB" was launched and disseminated at the consultation.

The World Health Organization (WHO) is seeking experts to serve as members on WHO Technical Advisory Group on clinical and policy considerations for new TB vaccines.

WHO publishes the report of the second meeting of PADO-TB2 group providing an updated list of priorities for paediatric formulations of TB medicines.

The World Health Organization (WHO) will host a global webinar on 5 June 2024 on its newly-released guidance on conducting reviews of TB programs and undertaking TB epidemiological reviews and assessments of TB surveillance and vital registration systems.

The World Health Organization (WHO) plans to update its guidance on use of interferon-gamma release assays (IGRAs) for the detection of TB infection. The aim of the update is to compare new (index) IGRAs with the IGRAs currently recommended by WHO (reference tests) for the diagnosis of TB infection.

Its goal is to ensure the continued worldwide standardization of TB surveillance, in the context of WHO’s End TB Strategy, the latest WHO guidelines on TB screening, prevention, diagnosis and treatment, and commitments made at the 2023 UN High-Level Meeting on TB.